These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 15173844)

  • 41. Determination of delta 9-tetrahydrocannabinol levels in brain tissue using high-performance liquid chromatography with electrochemical detection.
    Nyoni EC; Sitaram BR; Taylor DA
    J Chromatogr B Biomed Appl; 1996 Apr; 679(1-2):79-84. PubMed ID: 8998573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of haloperidol on the delta-9-tetrahydrocannabinol response in humans: a responder analysis.
    Gupta S; De Aquino JP; D'Souza DC; Ranganathan M
    Psychopharmacology (Berl); 2019 Sep; 236(9):2635-2640. PubMed ID: 30919005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats.
    Zamberletti E; Beggiato S; Steardo L; Prini P; Antonelli T; Ferraro L; Rubino T; Parolaro D
    Neurobiol Dis; 2014 Mar; 63():35-47. PubMed ID: 24200867
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis.
    Bhattacharyya S; Atakan Z; Martin-Santos R; Crippa JA; Kambeitz J; Malhi S; Giampietro V; Williams S; Brammer M; Rubia K; Collier DA; McGuire PK
    Eur Neuropsychopharmacol; 2015 Jan; 25(1):26-37. PubMed ID: 25532865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of acute cortisol and cocaine administration on attention, recall and recognition task performance in individuals with cocaine dependence.
    Hopper JW; Karlsgodt KH; Adler CM; Macklin EA; Lukas SE; Elman I
    Hum Psychopharmacol; 2004 Oct; 19(7):511-6. PubMed ID: 15378675
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nabilone produces marked impairments to cognitive function and changes in subjective state in healthy volunteers.
    Wesnes KA; Annas P; Edgar CJ; Deeprose C; Karlsten R; Philipp A; Kalliomäki J; Segerdahl M
    J Psychopharmacol; 2010 Nov; 24(11):1659-69. PubMed ID: 19525335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Neuropsychopharmacology of delta-9-tetrahydrocannabinol].
    Costentin J
    Ann Pharm Fr; 2008 Aug; 66(4):219-31. PubMed ID: 18847570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition.
    Otte C; Moritz S; Yassouridis A; Koop M; Madrischewski AM; Wiedemann K; Kellner M
    Neuropsychopharmacology; 2007 Jan; 32(1):232-8. PubMed ID: 17035932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of intrapulmonary tetrahydrocannabinol administration in humans.
    Zuurman L; Roy C; Schoemaker RC; Hazekamp A; den Hartigh J; Bender JC; Verpoorte R; Pinquier JL; Cohen AF; van Gerven JM
    J Psychopharmacol; 2008 Sep; 22(7):707-16. PubMed ID: 18515447
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Indlekofer F; Piechatzek M; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
    J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Substance use and cognition in early psychosis.
    Pencer A; Addington J
    J Psychiatry Neurosci; 2003 Jan; 28(1):48-54. PubMed ID: 12587850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.
    Weinstein A; Brickner O; Lerman H; Greemland M; Bloch M; Lester H; Chisin R; Sarne Y; Mechoulam R; Bar-Hamburger R; Freedman N; Even-Sapir E
    J Psychopharmacol; 2008 Jun; 22(4):441-51. PubMed ID: 18635724
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis.
    Colizzi M; Weltens N; McGuire P; Lythgoe D; Williams S; Van Oudenhove L; Bhattacharyya S
    Mol Psychiatry; 2020 Dec; 25(12):3231-3240. PubMed ID: 30770892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of Δ9-tetrahydrocannabinol administration on human encoding and recall memory function: a pharmacological FMRI study.
    Bossong MG; Jager G; van Hell HH; Zuurman L; Jansma JM; Mehta MA; van Gerven JM; Kahn RS; Ramsey NF
    J Cogn Neurosci; 2012 Mar; 24(3):588-99. PubMed ID: 22066583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.
    Hart CL; Ward AS; Haney M; Comer SD; Foltin RW; Fischman MW
    Psychopharmacology (Berl); 2002 Dec; 164(4):407-15. PubMed ID: 12457271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.
    Ramaekers JG; Kauert G; Theunissen EL; Toennes SW; Moeller MR
    J Psychopharmacol; 2009 May; 23(3):266-77. PubMed ID: 18719045
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers.
    Atakan Z; Bhattacharyya S; Allen P; Martín-Santos R; Crippa JA; Borgwardt SJ; Fusar-Poli P; Seal M; Sallis H; Stahl D; Zuardi AW; Rubia K; McGuire P
    Psychol Med; 2013 Jun; 43(6):1255-67. PubMed ID: 23020923
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder.
    Young AH; Gallagher P; Watson S; Del-Estal D; Owen BM; Ferrier IN
    Neuropsychopharmacology; 2004 Aug; 29(8):1538-45. PubMed ID: 15127079
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immediate and prolonged effects of cortisol, but not propranolol, on memory retrieval in healthy young men.
    Tollenaar MS; Elzinga BM; Spinhoven P; Everaerd W
    Neurobiol Learn Mem; 2009 Jan; 91(1):23-31. PubMed ID: 18761097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.